Margaret A Olsen1,2, Katelin B Nickel3, Julie A Margenthaler4, Ida K Fox5, Kelly E Ball3, Daniel Mines6, Anna E Wallace6, Graham A Colditz7, Victoria J Fraser3. 1. Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. molsen@dom.wustl.edu. 2. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA. molsen@dom.wustl.edu. 3. Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. 4. Division of General Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA. 5. Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA. 6. HealthCore, Inc., Wilmington, DE, USA. 7. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Abstract
BACKGROUND: Little data are available regarding individual patients' risk of surgical site infection (SSI) following mastectomy with or without immediate reconstruction. Our objective was to develop a risk prediction model for mastectomy-related SSI. METHODS: Using commercial claims data, we established a cohort of women <65 years of age who underwent a mastectomy from 1 January 2004-31 December 2011. International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes were used to identify SSI within 180 days after surgery. SSI risk factors were determined with multivariable logistic regression using derivation data from 2004-2008 and validated with 2009-2011 data using discrimination and calibration measures. RESULTS: In the derivation cohort, 595 SSIs were identified in 7607 (7.8 %) women, and 396 SSIs were coded in 4366 (9.1 %) women in the validation cohort. Independent risk factors for SSIs included rural residence, rheumatologic disease, depression, diabetes, hypertension, liver disease, obesity, pre-existing pneumonia or urinary tract infection, tobacco use disorder, smoking-related diseases, bilateral mastectomy, and immediate reconstruction. Receipt of home healthcare was associated with lower risk. The model performed equally in the validation cohort per discrimination (C-statistics 0.657 and 0.649) and calibration (Hosmer-Lemeshow p = 0.091 and 0.462 for derivation and validation, respectively). Three risk strata were created based on predicted SSI risk, which demonstrated good correlation with the proportion of observed infections in the strata. CONCLUSIONS: We developed and internally validated an SSI risk prediction model that can be used to counsel women with regard to their individual risk of SSI post-mastectomy. Immediate reconstruction, diabetes, and smoking-related diseases were important risk factors for SSI in this non-elderly population of women undergoing mastectomy.
BACKGROUND: Little data are available regarding individual patients' risk of surgical site infection (SSI) following mastectomy with or without immediate reconstruction. Our objective was to develop a risk prediction model for mastectomy-related SSI. METHODS: Using commercial claims data, we established a cohort of women <65 years of age who underwent a mastectomy from 1 January 2004-31 December 2011. International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes were used to identify SSI within 180 days after surgery. SSI risk factors were determined with multivariable logistic regression using derivation data from 2004-2008 and validated with 2009-2011 data using discrimination and calibration measures. RESULTS: In the derivation cohort, 595 SSIs were identified in 7607 (7.8 %) women, and 396 SSIs were coded in 4366 (9.1 %) women in the validation cohort. Independent risk factors for SSIs included rural residence, rheumatologic disease, depression, diabetes, hypertension, liver disease, obesity, pre-existing pneumonia or urinary tract infection, tobacco use disorder, smoking-related diseases, bilateral mastectomy, and immediate reconstruction. Receipt of home healthcare was associated with lower risk. The model performed equally in the validation cohort per discrimination (C-statistics 0.657 and 0.649) and calibration (Hosmer-Lemeshow p = 0.091 and 0.462 for derivation and validation, respectively). Three risk strata were created based on predicted SSI risk, which demonstrated good correlation with the proportion of observed infections in the strata. CONCLUSIONS: We developed and internally validated an SSI risk prediction model that can be used to counsel women with regard to their individual risk of SSI post-mastectomy. Immediate reconstruction, diabetes, and smoking-related diseases were important risk factors for SSI in this non-elderly population of women undergoing mastectomy.
Authors: Adeyemi A Ogunleye; Catherine de Blacam; Michael S Curtis; Salih Colakoglu; Adam M Tobias; Bernard T Lee Journal: J Plast Reconstr Aesthet Surg Date: 2011-10-17 Impact factor: 2.740
Authors: Michael S Gart; John T Smetona; Philip J Hanwright; Neil A Fine; Kevin P Bethke; Seema A Khan; Edward Wang; John Y S Kim Journal: J Am Coll Surg Date: 2012-12-02 Impact factor: 6.113
Authors: John Shepard; William Ward; Aaron Milstone; Taylor Carlson; John Frederick; Eric Hadhazy; Trish Perl Journal: JAMA Surg Date: 2013-10 Impact factor: 14.766
Authors: Margaret A Olsen; Mellani Lefta; Jill R Dietz; Keith E Brandt; Rebecca Aft; Ryan Matthews; Jennie Mayfield; Victoria J Fraser Journal: J Am Coll Surg Date: 2008-06-26 Impact factor: 6.113
Authors: Deborah S Yokoe; Gary A Noskin; Susan M Cunnigham; Gianna Zuccotti; Theresa Plaskett; Victoria J Fraser; Margaret A Olsen; Jerome I Tokars; Steven Solomon; Trish M Perl; Sara E Cosgrove; Richard S Tilson; Maurice Greenbaum; David C Hooper; Kenneth E Sands; John Tully; Loreen a Herwaldt; Daniel J Diekema; Edward S Wong; Michael Climo; Richard Platt Journal: Emerg Infect Dis Date: 2004-11 Impact factor: 6.883
Authors: John Y S Kim; Alexei S Mlodinow; Nima Khavanin; Keith M Hume; Christopher J Simmons; Michael J Weiss; Robert X Murphy; Karol A Gutowski Journal: Plast Reconstr Surg Glob Open Date: 2015-06-05
Authors: Margaret A Olsen; Katelin B Nickel; Victoria J Fraser; Anna E Wallace; David K Warren Journal: Infect Control Hosp Epidemiol Date: 2017-07-03 Impact factor: 3.254
Authors: Alexander Morzycki; Joseph Corkum; Nadim Joukhadar; Osama Samargandi; Jason G Williams; Simon G Frank Journal: Plast Surg (Oakv) Date: 2019-10-24 Impact factor: 0.947
Authors: Margaret A Olsen; Katelin B Nickel; Ida K Fox; Julie A Margenthaler; Anna E Wallace; Victoria J Fraser Journal: JAMA Surg Date: 2017-09-20 Impact factor: 14.766
Authors: Michael M Jonczyk; Carla Suzanne Fisher; Russell Babbitt; Jessica K Paulus; Karen M Freund; Brian Czerniecki; Julie A Margenthaler; Albert Losken; Abhishek Chatterjee Journal: Ann Surg Oncol Date: 2021-02-22 Impact factor: 4.339